PE-22-28 is an experimental short peptide described as a spadin-derived compound in neuroscience research. It is more specialized and less widely characterized than many catalog peptides and is investigated in neuropsychiatric research models. Supplied for laboratory research use only.
Frequently Asked Questions
Explore answers to our most commonly asked questions about CBD, our products, and more.
Researchers usually connect PE-22-28 with stress-response, potassium-channel and neuroplasticity-centered models. It remains an experimental neuroscience research compound. Supplied for laboratory research use only.